CD
NVS icon

Christopher Davis’s Novartis NVS Stock Holding History

Christopher Davis’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-28,943
Closed -$2.2M – 113
2022
Q3 		$2.2M Hold
28,943
– – 0.02% 107
2022
Q2 		$2.45M Sell
28,943
-3,713
-11% -$326K 0.02% 108
2022
Q1 		$2.87M Sell
32,656
-10,379
-24% -$899K 0.01% 111
2021
Q4 		$3.76M Sell
43,035
-1,933
-4% -$160K 0.02% 109
2021
Q3 		$3.68M Sell
44,968
-1,920
-4% -$173K 0.02% 110
2021
Q2 		$4.28M Buy
46,888
+2,464
+6% +$219K 0.02% 110
2021
Q1 		$3.8M Buy
44,424
+3,168
+8% +$284K 0.02% 103
2020
Q4 		$3.9M Buy
41,256
+2,408
+6% +$210K 0.02% 98
2020
Q3 		$3.38M Buy
38,848
+860
+2% +$74.5K 0.02% 99
2020
Q2 		$3.32M Buy
37,988
+10,148
+36% +$876K 0.02% 101
2020
Q1 		$2.29M Buy
27,840
+1,720
+7% +$153K 0.02% 107
2019
Q4 		$2.47M Buy
26,120
+2,064
+9% +$185K 0.01% 118
2019
Q3 		$2.09M Buy
24,056
+1,032
+4% +$92.7K 0.01% 120
2019
Q2 		$2.1M Sell
23,024
-751
-3% -$63.6K 0.01% 118
2019
Q1 		$2.05M Buy
23,775
+6,526
+38% +$524K 0.01% 120
2018
Q4 		$1.33M Sell
17,249
-158,602
-90% -$12.3M 0.01% 123
2018
Q3 		$13.6M Sell
175,851
-14,774
-8% -$1.09M 0.06% 90
2018
Q2 		$12.9M Sell
190,625
-38,664
-17% -$2.67M 0.05% 94
2018
Q1 		$16.6M Sell
229,289
-126,923
-36% -$9.66M 0.07% 77
2017
Q4 		$26.8M Sell
356,212
-34,596
-9% -$2.61M 0.11% 61
2017
Q3 		$30.1M Sell
390,808
-2,939
-0.7% -$222K 0.13% 68
2017
Q2 		$29.4M Buy
393,747
+60,387
+18% +$4.28M 0.13% 64
2017
Q1 		$22.2M Buy
333,360
+45,800
+16% +$3.05M 0.1% 72
2016
Q4 		$18.8M Buy
+287,560
New +$18.7M 0.08% 75
2013
Q3 		– Sell
-36,940
Closed -$2.34M – 204
2013
Q2 		$2.34M Buy
+36,940
New +$2.4M 0.01% 168

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Christopher Davis's NVS Position: Q4 2022 in Review

Christopher Davis sold out of Novartis (NVS) in Q4 2022, closing a stake of 28,943 shares — an estimated $2.2M sold.

Christopher Davis first reported a position in NVS in Q2 2013 and held it in 25 quarters. The position peaked at $30.1M in Q3 2017. 1,184 funds tracked by Wall St. Rank hold NVS as of Q4 2022.

  • Christopher Davis reported no remaining Novartis position as of Q4 2022 after selling out during the quarter.
  • Christopher Davis sold 28,943 Novartis shares in Q4 2022, an estimated $2.2M.
  • Christopher Davis first reported a position in Novartis in Q2 2013 and held it in 25 quarters.
  • Christopher Davis's Novartis position peaked at $30.1M in Q3 2017.
  • 1,184 funds tracked by Wall St. Rank held Novartis as of Q4 2022.

Based on Davis Selected Advisers's 13F filing for Q4 2022, filed 10 Feb 2023.